End-of-day quote
Shanghai S.E.
23:00:00 11/06/2024 BST
|
5-day change
|
1st Jan Change
|
34.18
CNY
|
+2.37%
|
|
+2.12%
|
-13.86%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,043
|
6,960
|
4,566
|
5,432
|
4,545
|
-
|
-
|
Enterprise Value (EV)
1 |
6,043
|
6,960
|
4,566
|
5,432
|
4,545
|
4,545
|
4,545
|
P/E ratio
|
28.7
x
|
29.1
x
|
18.5
x
|
41.3
x
|
20
x
|
14.9
x
|
12.9
x
|
Yield
|
-
|
1.71%
|
-
|
1.13%
|
2.02%
|
2.66%
|
3.69%
|
Capitalization / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
3.06
x
|
2.25
x
|
2.16
x
|
EV / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
3.06
x
|
2.25
x
|
2.16
x
|
EV / EBITDA
|
-
|
19.7
x
|
12
x
|
18.5
x
|
12
x
|
6.61
x
|
7.31
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.44
x
|
1.55
x
|
1.86
x
|
1.53
x
|
1.42
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
137,556
|
137,556
|
137,132
|
136,893
|
132,965
|
-
|
-
|
Reference price
2 |
43.93
|
50.60
|
33.29
|
39.68
|
34.18
|
34.18
|
34.18
|
Announcement Date
|
25/02/21
|
23/02/22
|
26/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,526
|
1,480
|
1,208
|
1,486
|
2,020
|
2,107
|
EBITDA
1 |
-
|
353.3
|
380
|
294.3
|
379
|
688
|
622
|
EBIT
1 |
-
|
272.3
|
275.5
|
147.4
|
219
|
346.5
|
397
|
Operating Margin
|
-
|
17.85%
|
18.61%
|
12.2%
|
14.74%
|
17.15%
|
18.84%
|
Earnings before Tax (EBT)
1 |
-
|
271.4
|
272.1
|
146.8
|
219
|
346.5
|
397
|
Net income
1 |
175.4
|
239.8
|
246.5
|
132.5
|
233.7
|
314.1
|
357
|
Net margin
|
-
|
15.72%
|
16.65%
|
10.97%
|
15.73%
|
15.55%
|
16.94%
|
EPS
2 |
1.531
|
1.740
|
1.800
|
0.9600
|
1.710
|
2.297
|
2.650
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.8674
|
-
|
0.4500
|
0.6900
|
0.9100
|
1.260
|
Announcement Date
|
25/02/21
|
23/02/22
|
26/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.8%
|
8.67%
|
8.53%
|
4.49%
|
7.5%
|
9.46%
|
10.4%
|
ROA (Net income/ Total Assets)
|
-
|
7.23%
|
-
|
3.98%
|
5.73%
|
7.8%
|
9.01%
|
Assets
1 |
-
|
3,317
|
-
|
3,332
|
4,079
|
4,027
|
3,962
|
Book Value Per Share
2 |
-
|
20.80
|
21.50
|
21.40
|
22.40
|
24.20
|
25.40
|
Cash Flow per Share
2 |
-
|
1.300
|
1.410
|
3.260
|
2.720
|
3.890
|
3.890
|
Capex
1 |
-
|
406
|
-
|
268
|
274
|
508
|
526
|
Capex / Sales
|
-
|
26.6%
|
-
|
22.18%
|
18.44%
|
25.12%
|
24.96%
|
Announcement Date
|
25/02/21
|
23/02/22
|
26/02/23
|
22/02/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -13.86% | 613M | | +5.69% | 103B | | -11.38% | 60.26B | | +67.14% | 45.41B | | +12.80% | 38.25B | | +0.87% | 31.37B | | +10.29% | 16.64B | | +7.82% | 13.86B | | -5.51% | 12.84B | | -24.66% | 12.43B |
Other Commodity Chemicals
|